1. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) J Biol Chem 278(15): 13480-6
    › Primary publication · 12566435 (PubMed)
  2. Impaired insulin secretion and glucose tolerance in beta cell-selective Ca(v)1.2 Ca2+ channel null mice. Schulla V, Renström E, Feil R, Feil S, Franklin I, Gjinovci A, Jing XJ, Laux D, Lundquist I, Magnuson MA, Obermüller S, Olofsson CS, Salehi A, Wendt A, Klugbauer N, Wollheim CB, Rorsman P, Hofmann F (2003) EMBO J 22(15): 3844-54
    › Primary publication · 12881419 (PubMed) · PMC169062 (PubMed Central)
  3. Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Martín J, Hunt SL, Dubus P, Sotillo R, Néhmé-Pélluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M (2003) Oncogene 22(34): 5261-9
    › Primary publication · 12917627 (PubMed)
  4. Gene-altered mice and metabolic flux control. Magnuson MA, She P, Shiota M (2003) J Biol Chem 278(35): 32485-8
    › Primary publication · 12788933 (PubMed)
  5. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. Ristow M, Mulder H, Pomplun D, Schulz TJ, Müller-Schmehl K, Krause A, Fex M, Puccio H, Müller J, Isken F, Spranger J, Müller-Wieland D, Magnuson MA, Möhlig M, Koenig M, Pfeiffer AF (2003) J Clin Invest 112(4): 527-34
    › Primary publication · 12925693 (PubMed) · PMC171391 (PubMed Central)
  6. Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Miyatsuka T, Kaneto H, Kajimoto Y, Hirota S, Arakawa Y, Fujitani Y, Umayahara Y, Watada H, Yamasaki Y, Magnuson MA, Miyazaki J, Hori M (2003) Biochem Biophys Res Commun 310(3): 1017-25
    › Primary publication · 14550306 (PubMed)
  7. Allosteric activators of glucokinase: potential role in diabetes therapy. Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF (2003) Science 301(5631): 370-3
    › Primary publication · 12869762 (PubMed)
  8. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA (2002) J Biol Chem 277(40): 37176-83
    › Primary publication · 12149271 (PubMed)
  9. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR (2002) Nat Genet 31(1): 111-5
    › Primary publication · 11923875 (PubMed)
  10. A functional link between glucokinase binding to insulin granules and conformational alterations in response to glucose and insulin. Rizzo MA, Magnuson MA, Drain PF, Piston DW (2002) J Biol Chem 277(37): 34168-75
    › Primary publication · 12101177 (PubMed)